Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Research and Innovation Action · Running

PFAROS Driving Sustainable Innovation to Minimise PFAS in European Healthcare

Coordinator
Universiteit Gent, Belgium
Runs
1 September 2026 to 31 August 2031
Status
Running
EU funding
€23.4m
Total cost
€41.0m
Partners
89 organisations in 16 countries
Type
Research and Innovation Action
Grant agreement
101251281

What the project is doing

In the project's own words, from its summary on CORDIS.

PFAROS is our European game-changing initiative to accelerate the transition away from harmful PFAS substances in the pharmaceutical and medical technology sectors. Aligned with EU public health, environmental, and industrial policy objectives, PFAROS is developing safe, scalable, and regulatory-ready alternatives, ensuring that healthcare innovation and sustainability go hand in hand. PFAROS’ mission is to replace PFAS in medical and pharmaceutical applications through a multidisciplinary approach, combining validated alternatives, advanced degradation and disposal technologies, and data science to support informed substitution and policy action.

At the core of PFAROS is a policy-informed, AI-powered data tool that maps PFAS use, identifies viable alternatives, and integrates life-cycle, exposure, and toxicological data—empowering evidence-based policy and regulatory decisions. Coupled with broad stakeholder engagement and social science integration, the project ensures a just and informed transition. PFAROS will ultimately unlock a PFAS-free future for Europe’s healthcare system by:1.

Developing an integrated testing and assessment framework to implement the safe and sustainable by design approach for PFAS replacement;2. Providing validated, industry-ready PFAS alternatives to ensure rapid adoption;3. Enabling data-driven decision-making through a PFAROS AI-powered data tool tailored to support regulatory needs;4. Setting the gold standard for sustainable alternatives and end-of-life solutions in critical applications;5.

Ensuring broad adoption and fostering cross-sector collaboration with industry, regulators, academia, and civil society;6. Positioning the EU as a global leader in sustainable chemical policy and healthcare innovation. PFAROS is more than a scientific initiative—it is a policy enabler, offering concrete tools and solutions to support a safer, greener, and more resilient healthcare system for Europe. The PFAROS project is a public private partnership (IHI).

Who is involved

OrganisationCityCountryRole
Universiteit GentGentBelgiumCoordinator
Universitat WienWienAustriaParticipant
Edwards Lifesciences Belgium BVDilbeekBelgiumParticipant
Health Care Without Harm EuropeBruxelles / BrusselBelgiumParticipant
InopsysMechelenBelgiumAssociatedpartner
Ion Beam Applications SAOttignies Louvain La NeuveBelgiumParticipant
Janssen Pharmaceutica NVBeerseBelgiumParticipant
Terumo EuropeLeuvenBelgiumParticipant
The European Association Medical Devices-Notified BodiesSprimontBelgiumParticipant
Ucb BiopharmaBruxelles / BrusselBelgiumParticipant
Ucb Pharma SABruxelles / BrusselBelgiumAssociatedpartner
Universiteit AntwerpenAntwerpenBelgiumParticipant
Vlaamse Instelling Voor Technologisch Onderzoek N.v.MolBelgiumParticipant
Ares Trading SACoinsinsSwitzerlandAssociatedpartner
Bayer Consumer Care AGBaselSwitzerlandAssociatedpartner
Cilag GmbH InternationalZugSwitzerlandAssociatedpartner
Edwards Lifesciences SARLNyonSwitzerlandAssociatedpartner
F. Hoffmann-La Roche AGBaselSwitzerlandParticipant
Merck Serono SAGeneveSwitzerlandAssociatedpartner
Novartis Pharma AGBaselSwitzerlandParticipant
Roche Diagnostics International AGRotkreuzSwitzerlandAssociatedpartner
Abbvie Deutschland GmbH & Co KgWiesbadenGermanyAssociatedpartner
Bayer AktiengesellschaftLeverkusenGermanyParticipant
Biotronik Se & Co. KgBerlinGermanyParticipant
Boehringer Ingelheim InternationalgmbhIngelheimGermanyParticipant
Boehringer Ingelheim Pharma GmbH &co KgIngelheimGermanyAssociatedpartner
Boehringer Ingelheim Corporate Center GmbHIngelheim am RheinGermanyAssociatedpartner
Dvgw Deutscher Verein Des Gas- Undwasserfaches - Technisch-Wissenschaftlicher Verein eVBonnGermanyParticipant
Edwards Lifesciences GmbHGarching B. MunchenGermanyAssociatedpartner
ElringKlinger Kunststofftechnik GmbHBietigheim-BissingenGermanyAssociatedpartner
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Lilly Deutschland GmbHBad HomburgGermanyAssociatedpartner
Medicalmountains GmbHTuttlingenGermanyParticipant
Merck Healthcare KgaaDarmstadtGermanyAssociatedpartner
Merck Kommanditgesellschaft Auf AktienDarmstadtGermanyParticipant
Merck Life Science KgaaDarmstadtGermanyAssociatedpartner
Olympus Winter & Ibe GmbHHamburgGermanyParticipant
Polysecure GmbHFreiburg Im BreisgauGermanyParticipant
Richard Wolf GmbHKnittlingenGermanyAssociatedpartner
Sanofi-Aventis Deutschland GmbHFrankfurt Am MainGermanyParticipant
Universitaetsklinikum Hamburg-EppendorfHamburgGermanyParticipant
Kobenhavns UniversitetKobenhavnDenmarkParticipant
Novo Nordisk A/sBagsvaerdDenmarkParticipant
Syddansk UniversitetOdense MDenmarkParticipant
Terumo Denmark, Filial Af Terumo Sweden ABHerlevDenmarkAssociatedpartner
Edwards Lifesciences SLValenciaSpainAssociatedpartner
Fundacio Institut Catala De Recerca De L'aiguaGironaSpainParticipant
Merck S.L.U.MadridSpainAssociatedpartner
Institut De Recherches Internationales ServierGif-Sur-YvetteFranceParticipant
Merck Santé S.A.S.LyonFranceAssociatedpartner
Oril IndustrieBolbecFranceAssociatedpartner
Sanofi R&d VaccinsLyonFranceAssociatedpartner
Sanofi Winthrop IndustrieGentillyFranceAssociatedpartner
Sanofi-Aventis Recherche & DeveloppementGentillyFranceAssociatedpartner
Technologie ServierOrleansFranceAssociatedpartner
Terumo France SASRueil-MalmaisonFranceAssociatedpartner
Janssen Sciences Ireland UCCorkIrelandAssociatedpartner
Pfizer Ireland PharmaceuticalsCorkIrelandAssociatedpartner
Pfizer Healthcare India Private LimitedTamilNaduIndiaAssociatedpartner
Merck Serono SpARomaItalyAssociatedpartner

And 29 more organisations. Full list on CORDIS.

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI